These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1059 related items for PubMed ID: 16055710

  • 1. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G, Malnou CE, Farras R, Andermarcher E, Hipskind R, Rodriguez M, Schmidt D, Muller S, Jariel-Encontre I, Piechaczyk M.
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [Abstract] [Full Text] [Related]

  • 2. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
    Deng T, Karin M.
    Nature; 1994 Sep 08; 371(6493):171-5. PubMed ID: 8072547
    [Abstract] [Full Text] [Related]

  • 3. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A, Cuozzo C, Esposito I, Maggiolini M, Bonofiglio D, Vivacqua A, Garramone M, Weiss C, Bohmann D, Musti AM.
    Oncogene; 2002 Sep 19; 21(42):6434-45. PubMed ID: 12226747
    [Abstract] [Full Text] [Related]

  • 4. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS, Hasson B, Boyer-Boiteau A, El-Khishin A, Shashoua VE.
    J Neurosci Res; 2003 May 01; 72(3):405-16. PubMed ID: 12692907
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
    Ikari A, Sanada A, Okude C, Sawada H, Yamazaki Y, Sugatani J, Miwa M.
    J Cell Physiol; 2010 Mar 01; 222(3):481-7. PubMed ID: 19937979
    [Abstract] [Full Text] [Related]

  • 6. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR, Tae HJ, Mitin N, Taparowsky EJ.
    Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209
    [Abstract] [Full Text] [Related]

  • 7. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K, Colburn NH.
    Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401
    [Abstract] [Full Text] [Related]

  • 8. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR, Kerppola TK.
    J Mol Biol; 2001 Jan 19; 305(3):411-27. PubMed ID: 11152600
    [Abstract] [Full Text] [Related]

  • 9. SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation.
    Tempé D, Vives E, Brockly F, Brooks H, De Rossi S, Piechaczyk M, Bossis G.
    Oncogene; 2014 Feb 13; 33(7):921-7. PubMed ID: 23396363
    [Abstract] [Full Text] [Related]

  • 10. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
    Schuringa JJ, Timmer H, Luttickhuizen D, Vellenga E, Kruijer W.
    Cytokine; 2001 Apr 21; 14(2):78-87. PubMed ID: 11356008
    [Abstract] [Full Text] [Related]

  • 11. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2006 Nov 21; 99(4):1237-50. PubMed ID: 17026529
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH, Chen TK, Birrer MJ.
    Oncogene; 1994 Mar 21; 9(3):791-9. PubMed ID: 8108121
    [Abstract] [Full Text] [Related]

  • 13. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S, Brown PH, Birrer MJ.
    Oncogene; 1996 Mar 07; 12(5):1043-53. PubMed ID: 8649795
    [Abstract] [Full Text] [Related]

  • 14. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M, Bister K.
    Oncogene; 1998 Dec 03; 17(22):2901-13. PubMed ID: 9879996
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
    Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA.
    Carcinogenesis; 2004 Feb 03; 25(2):249-61. PubMed ID: 14604893
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M.
    Nature; 1991 Dec 12; 354(6353):494-6. PubMed ID: 1749429
    [Abstract] [Full Text] [Related]

  • 17. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
    Bakiri L, Takada Y, Radolf M, Eferl R, Yaniv M, Wagner EF, Matsuo K.
    Bone; 2007 Apr 12; 40(4):867-75. PubMed ID: 17189721
    [Abstract] [Full Text] [Related]

  • 18. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A.
    Oncogene; 2000 Aug 17; 19(35):4011-21. PubMed ID: 10962557
    [Abstract] [Full Text] [Related]

  • 19. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A, Shealy YF, Hill DL, Zhang X.
    Cancer Res; 1997 Aug 15; 57(16):3444-50. PubMed ID: 9270011
    [Abstract] [Full Text] [Related]

  • 20. Role of c-Jun concentration in neuronal cell death.
    Rössler OG, Steinmüller L, Giehl KM, Thiel G.
    J Neurosci Res; 2002 Dec 01; 70(5):655-64. PubMed ID: 12424733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.